Press Releases

Year

March 25, 2020

Establishment Labs Receives Issuance for Key U.S. Patent Covering Company’s Implant Surface Technology

NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the U.S. Patent & Trademark Office has issued a patent protecting

March 16, 2020

Establishment Labs Reports Fourth Quarter and Full Year 2019 Financial Results

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended

March 3, 2020

Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16

NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the

February 25, 2020

ESTA Announces Participation at the Cowen and Company 40th Annual Health Care Conference

NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that CEO and Founder Juan José Chacón-Quirós will participate at the

February 3, 2020

Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NEW YORK, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the closing of its previously announced public

January 29, 2020

Establishment Labs Announces Pricing of Public Offering of Common Shares

NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the pricing of its public offering of 2,285,714 common

January 28, 2020

Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue

NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced preliminary financial results for the fourth quarter and full year

January 28, 2020

Establishment Labs Announces Proposed Public Offering of Common Shares

NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that it has commenced a public offering of

Investors

Press Releases

Press Releases